EX-23.1 3 e3112_ex23-1.htm EXHIBIT 23.1

 

 

EXHIBIT 23.1

 

Consent of Independent Registered Public Accounting Firm

 

Anavex Life Sciences Corp.

New York, New York

 

We hereby consent to the incorporation by reference in the Prospectus constituting a part of this Registration Statement of our report dated December 28, 2020, relating to the consolidated financial statements of Anavex Life Sciences Corp. appearing in the Company’s Annual Report on Form 10-K for the year ended September 30, 2020.

 

We also consent to the reference to us under the caption “Experts” in the Prospectus.

 

/s/ BDO USA, LLP

New York, New York

September 24, 2021